Prostate cancer Board decisions

The Board has remanded the Veteran's claims for erectile dysfunction and prostate cancer due to herbicide exposure as there is insufficient evidence to determine if he was exposed to herbicides in service. The Veteran will need to provide additional records, and a VA examination will be conducted to assess his conditions and their relationship to service.

The Board has remanded the claims for service connection for various conditions due to additional development being required.

The Veteran's death was caused by prostate cancer, and the Board found that his multiple hazardous chemical exposures during service could not be definitively ruled out as a cause. The Board granted service connection for the cause of the Veteran's death based on reasonable doubt.

The Board denied the Veteran's claims for service connection for diabetes mellitus, hypertension, and prostate cancer due to a lack of evidence of herbicide agent exposure during active service. The disabilities were not shown to have onset in service or be related to service.

The Veteran's claim for service connection for prostate cancer and psychiatric disability was granted. The claims for hypertension, dental disability, vision disability, and headaches are remanded.

The Board has found that a remand is necessary to obtain potentially outstanding records, including SSA disability benefits and medical records. The Veteran's claim for service connection for prostate cancer is also remanded due to the possibility of exposure to herbicide agents during his service in Korea and Vietnam.

The Board has granted the reopening of the claim for service connection for diabetes mellitus, but denied both the original and reopened claims for service connection for prostate cancer.

The Veteran's service connection claims for coronary artery disease and prostate cancer are granted due to presumed exposure to herbicide agents during his time in Thailand.

The Veteran's service-connected disabilities do not preclude him from obtaining and retaining substantially gainful employment.

The Veteran's prostate cancer is currently rated at 100 percent, and the claim for a higher rating is granted. The claims for increased ratings of left lower extremity lymphedema and right lower extremity lymphedema are remanded.

The Board has decided to remand the case due to insufficient evidence regarding the Veteran's exposure to herbicides in Thailand, which could affect his claim for service connection of prostate cancer as secondary to such exposure.

The Board denied service connection for prostate cancer, coronary artery disease, liver disease, erectile dysfunction, kidney disease, and pigmentation scar on the head. The claim for prostate cancer was reopened based on new evidence, but it was still denied as there is no direct or presumptive link to service.,Service connection for coronary artery disease, liver disease, erectile dysfunction, and kidney disease were also denied due to lack of in-service diagnosis or chronicity.

The Veteran's service-connected disabilities, including prostate cancer, PTSD, diabetes, and peripheral neuropathy, have rendered him unable to secure or follow a substantially gainful occupation.

The Veteran's service-connected conditions do not render him unable to secure and follow a substantially gainful occupation.

The Veteran's claims for service connection for prostate cancer and diabetes mellitus were denied as there was no evidence linking these conditions to his military service, including exposure to herbicide agents.

The Veteran's claims for service connection and increased ratings were denied. The Veteran was granted a TDIU from January 6, 2015 to May 20, 2018.

The Board has dismissed the appeals for a rating in excess of 50 percent for bilateral hearing loss and TDIU. The prostate cancer claim is remanded due to insufficient development, including verification of herbicide exposure and a VA medical opinion on the relationship between service-connected epididymitis and prostate cancer.

The Board denied both the Veteran's claims for service connection for prostate cancer and erectile dysfunction as secondary to prostate cancer, finding that there was no evidence linking these conditions to his active duty service.

The Board previously denied the Veteran's claim for service connection of prostate cancer. The CAVC found that the prior decision was inadequate due to a misstatement regarding the Veteran’s dose estimate and an insufficient rationale provided based on the incorrect estimate. The case is now remanded for an addendum opinion from the medical professional who conducted the December 2016 VA examination.

The Board found that a reduction of the evaluation for prostate cancer from 100 percent to 40 percent, effective March 1, 2013, was proper. The Veteran's residuals of prostate cancer were characterized by voiding dysfunction and required changing absorbent materials more than four times per day after December 24, 2013, warranting a 60% rating.